Skip to main content
. 2004 Apr;78(8):4020–4028. doi: 10.1128/JVI.78.8.4020-4028.2004

FIG. 3.

FIG. 3.

Protection against infection with high dose of L.m.-OVA. C57BL/6 mice were vaccinated with T0H-OVA, T0-GFP (4 × 106 virus particles i.v.), or pcDNA3-OVA and infected with 105 (four times the LD50) L.m.-OVA cells 7 days postvaccination. Mice were sacrificed 3 days after infection, and bacterial counts in spleen (a) and livers (b) were determined from organ homogenates (n = 3 to 4 mice per group). (c) Differentially vaccinated mice (three or four per group) were infected with 5 × 105 (20 times the LD50) L.m.-OVA cells, and survival was monitored for 13 days.